TrialThe Journal of clinical investigation2014

PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.

Alena Gros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.